New Developments in Insomnia Medications of Relevance to Mental Health Disorders.
Publication
, Journal Article
Krystal, AD
Published in: Psychiatr Clin North Am
December 2015
Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." A new paradigm for insomnia therapy in which specific drugs are selected to target the specific type of sleep difficulty for each patient includes administering specific treatments for patients with insomnia comorbid with particular psychiatric disorders. This article reviews insomnia medications and discusses the implications for optimizing the treatment of insomnia occurring comorbid with psychiatric conditions.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Psychiatr Clin North Am
DOI
EISSN
1558-3147
Publication Date
December 2015
Volume
38
Issue
4
Start / End Page
843 / 860
Location
United States
Related Subject Headings
- Sleep Initiation and Maintenance Disorders
- Receptors, Melatonin
- Psychiatry
- Orexin Receptor Antagonists
- Mental Disorders
- Humans
- Histamine Antagonists
- Benzodiazepines
- Antipsychotic Agents
- Antidepressive Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Krystal, A. D. (2015). New Developments in Insomnia Medications of Relevance to Mental Health Disorders. Psychiatr Clin North Am, 38(4), 843–860. https://doi.org/10.1016/j.psc.2015.08.001
Krystal, Andrew D. “New Developments in Insomnia Medications of Relevance to Mental Health Disorders.” Psychiatr Clin North Am 38, no. 4 (December 2015): 843–60. https://doi.org/10.1016/j.psc.2015.08.001.
Krystal AD. New Developments in Insomnia Medications of Relevance to Mental Health Disorders. Psychiatr Clin North Am. 2015 Dec;38(4):843–60.
Krystal, Andrew D. “New Developments in Insomnia Medications of Relevance to Mental Health Disorders.” Psychiatr Clin North Am, vol. 38, no. 4, Dec. 2015, pp. 843–60. Pubmed, doi:10.1016/j.psc.2015.08.001.
Krystal AD. New Developments in Insomnia Medications of Relevance to Mental Health Disorders. Psychiatr Clin North Am. 2015 Dec;38(4):843–860.
Published In
Psychiatr Clin North Am
DOI
EISSN
1558-3147
Publication Date
December 2015
Volume
38
Issue
4
Start / End Page
843 / 860
Location
United States
Related Subject Headings
- Sleep Initiation and Maintenance Disorders
- Receptors, Melatonin
- Psychiatry
- Orexin Receptor Antagonists
- Mental Disorders
- Humans
- Histamine Antagonists
- Benzodiazepines
- Antipsychotic Agents
- Antidepressive Agents